Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
acute hemodynamic effects of tpn171h in pulmonary arterial hypertension a randomized controlled phase 2a trial
Original title: “Acute hemodynamic effects of TPN171H in pulmonary arterial hypertension: a randomized, controlled, phase 2a trial.”
prognostic performance of esc ers guideline recommended echocardiographic risk markers in prevalent pulmonary arterial hypertension
Original title: “Prognostic performance of ESC/ERS guideline-recommended echocardiographic risk markers in prevalent pulmonary arterial hypertension.”
application of a prevalence adjusted cost effectiveness threshold framework for pulmonary arterial hypertension
Original title: “Application of a Prevalence-Adjusted Cost-Effectiveness Threshold Framework for Pulmonary Arterial Hypertension.”
when history can mislead a physician a challenging case report of idiopathic pulmonary hemosiderosis a case report and review of the literature
Original title: “When history can mislead a physician: a challenging case report of idiopathic pulmonary hemosiderosis-A case report and review of the literature.”
treatment of pulmonary arterial hypertension in lithuania current situation and analysis of survival of patients treated with different treatment regimens
Original title: “Treatment of Pulmonary Arterial Hypertension in Lithuania: Current Situation and Analysis of Survival of Patients Treated with Different Treatment Regimens.”
Gossamer Bio reported last month that its only late-stage candidate failed a Phase 3 study in pulmonary arterial hypertension, casting doubt on the asset's future prospects.
Original title: “Gossamer Nearly Halves Workforce in Savings Push After Late-Stage Hypertension Fail”
sotatercept for decompensated pulmonary arterial hypertension requiring va ecmo first canadian icu experience
Original title: “Sotatercept for Decompensated Pulmonary Arterial Hypertension Requiring VA ECMO: First Canadian ICU Experience.”
pah former transfer learning for efficient discovery of pulmonary arterial hypertension associated genes
Original title: “PAH-former: Transfer learning for efficient discovery of pulmonary arterial hypertension-associated genes.”
The deal hands GSK a drug it views as a potentially “best-in-class” therapy for blood pressure diseases like pulmonary arterial hypertension — the target of Merck’s fast-selling Winrevair.
Original title: “GSK to acquire 35Pharma in $950M deal for cardiovascular drug”
Following a disappointing Phase 3 performance and given Gossamer Bio’s balance sheet, seralutinib’s path to the market for pulmonary arterial hypertension has become unclear, according to analysts at Guggenheim Partners.
Original title: “Gossamer Nosedives as Late-Stage Failure Plunges PAH Program Into Uncertainty”
management of pulmonary arterial hypertension in systemic sclerosis from classical treatments to new horizons
Original title: “Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons.”
healthcare resource utilization and medical costs in pulmonary arterial hypertension management in japan a retrospective study using a claims database
Original title: “Healthcare Resource Utilization and Medical Costs in Pulmonary Arterial Hypertension Management in Japan: A Retrospective Study Using a Claims Database.”
large animal model of heritable pulmonary arterial hypertension using gene edited bmpr2 sheep
Original title: “A Large Animal Model of Heritable Pulmonary Arterial Hypertension Using Gene-edited BMPR2 Sheep.”